Home › Funds › Diametric Capital, LP › ZVRA
Diametric Capital, LP position in ZVRA
ZEVRA THERAPEUTICS INC · Health Care
Diametric Capital, LP reported holding 231,465 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.3M, representing 0.37% of its reported portfolio and ranking #40 among its reported holdings. Diametric Capital, LP has disclosed ZVRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Diametric Capital, LP's ZVRA position evolved
Diametric Capital, LP first disclosed a stake in ZVRA in Q1 2026 at 108,024 shares (US$1.0M). The position peaked in Q2 2026 at 231,465 shares, worth US$3.3M. Across 2 filings, Diametric Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 231,465 shares valued at US$3.3M — an increase of 123,441 shares quarter over quarter.. Notable position changes include a 114% increase in Q2 2026 (shares fell 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 108.02K | $1.01M | New |
| Q2 2026 | 231.47K | $3.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZVRA and 13F data
ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZVRA
- Nantahala Capital Management, LLC 1.80M sh · $25.78M · Q2 2026
- 683 Capital Management, LLC 855.00K sh · $12.26M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 775.00K sh · $11.11M · Q2 2026
- Retirement Planning Co of New England, Inc. 612.33K sh · $6.72M · Q3 2026
- Mystic Asset Management, Inc. 355.38K sh · $3.90M · Q3 2026
- Stonepine Capital Management, LLC 258.70K sh · $3.71M · Q2 2026
- Propel Bio Management, LLC 253.54K sh · $3.64M · Q2 2026
More on Diametric Capital, LP
FAQ
How long has Diametric Capital, LP held ZVRA?
Diametric Capital, LP has disclosed ZVRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Diametric Capital, LP's current position in ZVRA?
As of Q2 2026, Diametric Capital, LP holds 231.47K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $3.32M, representing 0.37% of its reported portfolio and ranking #40.
Has Diametric Capital, LP been buying or selling ZVRA?
In the latest 13F filing (Q2 2026), Diametric Capital, LP increased its position in ZVRA. The position peaked in Q2 2026 at 231.47K shares.
Which other funds hold ZVRA?
Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.